Renishaw plc
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Renishaw plc, founded in 1973 and headquartered in Wotton-under-Edge, Gloucestershire, UK, develops, manufactures and markets precision metrology, motion control, healthcare, spectroscopy and additive manufacturing technologies for industrial and medical applications; core products include touch-trigger probes, scanning probes and machine tool probes for coordinate measuring machines, gauging systems such as Equator and AGILITY CMMs, linear and rotary encoder systems including laser, optical, magnetic and the new ASTRiA inductive encoders, calibration systems, additive manufacturing machines like RenAM 500 series with TEMPUS and dual-laser technology, Raman spectroscopy instruments, neurosurgical robots such as neuromate, dental CAD/CAM systems and analytical instruments for biochemical analysis. The company operates through manufacturing technologies encompassing industrial metrology and position measurement, alongside analytical instruments and medical devices segments, serving aerospace, automotive, semiconductor, power generation, consumer electronics, defence, robotics and healthcare markets with facilities in the UK, Ireland, India and research sites in Edinburgh and Ljubljana; it maintains a global presence across Americas, EMEA and APAC regions with customer support in over 35 countries. Recent developments include the launch of RMP24-micro wireless probe, Opti-Logic twin probe technology, next-generation laser encoders, RenAM 500D dual-laser AM machine, Equator-X gauging system with MODUS IM software and ASTRiA encoders using a minimum viable product approach; the company completed expansion of its Miskin, Wales manufacturing facility, exited the loss-making neurological drug delivery business for £3m annualised profit benefit while seeking a buyer for remaining neurosurgical activities, closed its Edinburgh research facility, implemented a £20m annualised payroll reduction programme via redundancies effective FY2026 H1, invested in manufacturing automation, global ERP including Microsoft Dynamics 365, e-commerce platform and AI productivity tools, and reported record FY2025 revenue of £713m with 3.1% growth, improved gross margins to 61.7% and proposed a 2.5% higher full-year dividend.
Company News
Renishaw plc (RNSHF) Q4 2026 Earnings Call Transcript
Renishaw posts record profit as semiconductor demand drives growth
Jefferies turns bullish on Renishaw and XP Power as chip cycle powers on
Renishaw jumps as profits expected to beat forecasts thanks to semiconductor and electronics demand
Renishaw plc (RNSHF) Analyst/Investor Day Transcript
Renishaw Highlights AI Chip, Defense and Additive Growth at Capital Markets Day
Renishaw hikes outlook again thanks to strong demand from semiconductor market
RENISHAW PLC 20 (OTCMKTS:RNSHF) Short Interest Down 84.3% in March
RENISHAW PLC 20 (OTCMKTS:RNSHF) and Mogo (NASDAQ:MOGO) Critical Review
Short Interest in RENISHAW PLC 20 (OTCMKTS:RNSHF) Declines By 13.7%
Renishaw raises guidance as analyst say currency swings mask momentum
Renishaw plc (RNSHF) Q2 2026 Earnings Call Transcript
Britain's Renishaw projects annual profit, revenue growth; shares jump
Spirax, Halma and Renishaw the pick of UK engineers, says leading bank
Renishaw plc (RNSHF) Q4 2025 Earnings Call Transcript
Renishaw hits record sales as resurgent semiconductor market points to further growth
Renishaw shares climb 9% as profits set to hit top of forecasts
Renishaw ups guidance and introduces surcharge to pass on US tariff costs
Renishaw reports 2% profit growth but expects second half pickup
Continuum Powders Qualifies Reclaimed Metal Powders for Renishaw's RenAM 500